Abstract
Bacterial infections are a major threat to human health in the USA and globally. The modern patient is increasingly susceptible to severe infections due to the use of invasive implants, cancer therapies, and the rapid emergence of multidrug-resistant bacteria. Overuse and misuse of antimicrobials are costing billions of dollars to the US health system with similar patterns in other developed and developing countries. Molecular imaging is a promising tool for the early diagnosis, and targeted pharmaceutical intervention of bacterial infection, which could significantly improve patient care and reduce costs worldwide.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Keen, E.F., III, et al., Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center. Infect.Control Hosp.Epidemiol., 2010. 31(7): p. 728-732.
McKenna, M., Antibiotic resistance: the last resort. Nature, 2013. 499(7459): p. 394-6.
Nordmann, P., L. Dortet, and L. Poirel, Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med, 2012. 18(5): p. 263-72.
Melzer, M. and I. Petersen, Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect, 2007. 55(3): p. 254-9.
Salazar-Austin, N., et al., Extensively drug-resistant tuberculosis in a young child after travel to India. Lancet Infect Dis, 2015. 15(12): p. 1485-91.
Velayati, A.A., et al., Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest, 2009. 136(2): p. 420-5.
McCaughey, B. Unnecessary Deaths: The Human and Financial Costs of Hospital Infections. 2nd Edition November 13, 2016]; Available from: http://emerald.tufts.edu/med/apua/consumers/faqs_2_4154863510.pdf.
Falagas, M.E., et al., Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother, 2014. 58(2): p. 654-63.
Donnenberg, M.S., Enterobacteriaceae, in Mandell, Douglas, and Bennett’s principles and practice of infectious diseases., J.E.B. Gerald L. Mandell, and Raphael Dolin, Editor. 2010, Elsevier Inc: Philadelphia, PA. p. 2815-2833.
Zackrisson, S., S.M. van de Ven, and S.S. Gambhir, Light in and sound out: emerging translational strategies for photoacoustic imaging. Cancer Res, 2014. 74(4): p. 979-1004.
Lai, P.H., et al., Pyogenic brain abscess: findings from in vivo 1.5-T and 11.7-T in vitro proton MR spectroscopy. AJNR Am J Neuroradiol, 2005. 26(2): p. 279-88.
Liu, G., et al., Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI. Magn Reson Med, 2013. 70(6): p. 1690-8.
Gemmel, F., N. Dumarey, and M. Welling, Future diagnostic agents. Semin Nucl Med, 2009. 39(1): p. 11-26.
van Oosten, M., et al., Targeted imaging of bacterial infections: advances, hurdles and hopes. FEMS Microbiol Rev, 2015. 39(6): p. 892-916.
Vinjamuri, S., et al., Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet, 1996. 347(8996): p. 233-5.
Sarda, L., et al., Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med, 2003. 44(6): p. 920-6.
Palestro, C., et al., Phase II study of 99mTc-ciprofloxacin uptake in patients with high suspicion of osteomyelitis. J Nucl Med, 2006. 47(suppl 1): p. 152P.
Ebenhan, T., et al., Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med, 2014. 55(2): p. 308-14.
Vilche, M., et al., 68Ga-NOTA-UBI-29-41 as a PET Tracer for Detection of Bacterial Infection. J Nucl Med, 2016. 57(4): p. 622-7.
Welling, M., et al., The many roads to infection imaging. Eur J Nucl Med Mol Imaging, 2008. 35(4): p. 848-9.
Wiehr, S., et al., New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection. Oncotarget, 2016. 7(10): p. 10990-1001.
Mac Faddin, J.F., Biochemical tests for identification of medical bacteria. 1976, Baltimore, MD: The Williams & Wilkins Company. 312.
Ordonez, A.A., et al., A Systematic Approach for Developing Bacteria-Specific Imaging Tracers. J Nucl Med, 2017. 58(1): p. 144-150.
Konig, C., H.P. Simmen, and J. Blaser, Bacterial concentrations in pus and infected peritoneal fluid--implications for bactericidal activity of antibiotics. J Antimicrob Chemother, 1998. 42(2): p. 227-32.
Jang, K., et al., Treatment of prostatic abscess: case collection and comparison of treatment methods. Korean J Urol, 2012. 53(12): p. 860-4.
Yamamoto, M., et al., Treatment of bacterial brain abscess by repeated aspiration--follow up by serial computed tomography. Neurol Med Chir (Tokyo), 2000. 40(2): p. 98-104.; discussion 104-5.
Vaidyanathan, S., et al., FDG PET/CT in infection and inflammation--current and emerging clinical applications. Clin Radiol, 2015. 70(7): p. 787-800.
Marjanovic, S., et al., Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res, 1991. 193(2): p. 425-31.
Jamar, F., et al., EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med, 2013. 54(4): p. 647-58.
Chen, R.Y., et al., PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis. Sci Transl Med, 2014. 6(265): p. 265ra166.
Love, C., S.E. Marwin, and C.J. Palestro, Nuclear medicine and the infected joint replacement. Semin Nucl Med, 2009. 39(1): p. 66-78.
Treglia, G., et al., Diagnostic performance of Fluorine-18-Fluorodeoxyglucose positron emission tomography for the diagnosis of osteomyelitis related to diabetic foot: a systematic review and a meta-analysis. The Foot, 2013. 23(4): p. 140-148.
Mills, B., et al., [(18)F]FDG-6-P as a novel in vivo tool for imaging staphylococcal infections. EJNMMI Res, 2015. 5: p. 13.
Lengeler, J., Nature and properties of hexitol transport systems in Escherichia coli. J Bacteriol, 1975. 124(1): p. 39-47.
Scott, M.E. and R.E. Viola, The use of fluoro-and deoxy-substrate analogs to examine binding specificity and catalysis in the enzymes of the sorbitol pathway. Carbohydrate research, 1998. 313(3): p. 247-253.
Li, Z.-B., et al., The Synthesis of 18F-FDS and Its Potential Application in Molecular Imaging. Molecular Imaging and Biology, 2008. 10: p. 92-98.
Weinstein, E.A., et al., Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Science translational medicine, 2014. 6(259): p. 259ra146-259ra146.
Zhu, W., et al., Biodistribution and Radiation Dosimetry of the Enterobacteriaceae-Specific Imaging Probe [18F]Fluorodeoxysorbitol Determined by PET/CT in Healthy Human Volunteers. Molecular Imaging and Biology, 2016. 18(5): p. 782-787.
Shuman, H.A. and N.A. Treptow, The Maltose-Maltodextrin-Transport System of Escherichia coli K-12, in The Enzymes of Biological Membranes, A. Martonosi, Editor. 2012, Springer Science & Business Media. p. 561-572.
Ning, X., et al., Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat Mater, 2011. 10(8): p. 602-607.
Ning, X., et al., PET Imaging of Bacterial Infections with Fluorine-18-Labeled Maltohexaose. Angewandte Chemie International Edition, 2014. 53(51): p. 14096-14101.
Gowrishankar, G., et al., Investigation of 6-[18F]-Fluoromaltose as a Novel PET Tracer for Imaging Bacterial Infection. PLOS ONE, 2014. 9(9): p. e107951.
Tournu, H., A. Fiori, and P. Van Dijck, Relevance of Trehalose in Pathogenicity: Some General Rules, Yet Many Exceptions. PLOS Pathogens, 2013. 9(8): p. e1003447.
Backus, K.M., et al., Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis. Nat Chem Biol, 2011. 7(4): p. 228-35.
Rundell, S.R., et al., Deoxyfluoro-d-trehalose (FDTre) analogues as potential PET probes for imaging mycobacterial infection. Org Biomol Chem, 2016. 14(36): p. 8598-609.
Bettegowda, C., et al., Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A, 2005. 102(4): p. 1145-50.
Pullambhatla, M., et al., [(125)I]FIAU imaging in a preclinical model of lung infection: quantification of bacterial load. Am J Nucl Med Mol Imaging, 2012. 2(3): p. 260-70.
Diaz, L.A., Jr., et al., Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT. PLoS One, 2007. 2(10): p. e1007.
Zhang, X.M., et al., [124I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection. Nuclear Medicine and Biology, 2016. 43(5): p. 273-279.
Kuru, E., et al., In Situ probing of newly synthesized peptidoglycan in live bacteria with fluorescent D-amino acids. Angew Chem Int Ed Engl, 2012. 51(50): p. 12519-23.
MartÃnez, M.E., et al., New radiosynthesis of 2-deoxy-2-[18F]fluoroacetamido-d-glucopyranose and its evaluation as a bacterial infections imaging agent. Nuclear Medicine and Biology, 2011. 38(6): p. 807-817.
Littenberg, R.L., et al., Gallium-67 for localization of septic lesions. Ann Intern Med, 1973. 79(3): p. 403-6.
Tzen, K.Y., et al., Role of iron-binding proteins and enhanced capillary permeability on the accumulation of gallium-67. J Nucl Med, 1980. 21(1): p. 31-5.
Weiner, R., P.B. Hoffer, and M.L. Thakur, Lactoferrin: its role as a Ga-67-binding protein in polymorphonuclear leukocytes. J Nucl Med, 1981. 22(1): p. 32-7.
Menon, S., H.N. Wagner, Jr., and M.F. Tsan, Studies on gallium accumulation in inflammatory lesions: II. Uptake by Staphylococcus aureus: concise communication. J Nucl Med, 1978. 19(1): p. 44-7.
Kumar, V. and D.K. Boddeti, 68Ga-Radiopharmaceuticals for PET Imaging of Infection and Inflammation, in Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment, R.P. Baum and F. Rösch, Editors. 2013, Springer Berlin Heidelberg: Berlin, Heidelberg. p. 189-219.
Tsan, M.F., Mechanism of gallium-67 accumulation in inflammatory lesions. J Nucl Med, 1985. 26(1): p. 88-92.
Palestro, C.J., The current role of gallium imaging in infection. Semin Nucl Med, 1994. 24(2): p. 128-41.
Makinen, T.J., et al., Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus. Eur J Nucl Med Mol Imaging, 2005. 32(11): p. 1259-68.
Kumar, V., et al., (68)Ga-Citrate-PET for diagnostic imaging of infection in rats and for intra-abdominal infection in a patient. Curr Radiopharm, 2012. 5(1): p. 71-5.
Vorster, M., et al., 68Ga-citrate PET/CT in Tuberculosis: A pilot study. The quarterly journal of nuclear medicine and molecular imaging: official publication of the Italian Association of Nuclear Medicine (AIMN)[and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of 2014.
Kumar, V., et al., Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection. Nuclear Medicine and Biology, 2011. 38(3): p. 393-398.
Petrik, M., et al., 68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle. J Nucl Med, 2010. 51(4): p. 639-45.
Kong, Y., et al., Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci U S A, 2010. 107(27): p. 12239-44.
Lentz, C.S., et al., Design of Selective Substrates and Activity-Based Probes for Hydrolase Important for Pathogenesis 1 (HIP1) from Mycobacterium tuberculosis. ACS Infect Dis, 2016. 2(11): p. 807-815.
Tsopelas, C., Radiotracers used for the scintigraphic detection of infection and inflammation. ScientificWorldJournal, 2015. 2015: p. 676719.
Solanki, K., et al., Tc-99m Infecton: a new class of radiopharmaceutical for imaging infection. Journal of Nuclear Medicine, 1993. 34(5): p. P119-P119.
Britton, K.E., et al., Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. European Journal of Nuclear Medicine, 1997. 24(5): p. 553-556.
Britton, K.E., et al., Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton). Journal of Clinical Pathology, 2002. 55(11): p. 817-823.
Sarda, L., et al., Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med, 2002. 43(2): p. 239-45.
Dumarey, N. and A. Schoutens, Renal abscess: filling in with Tc-99m ciprofloxacin of defects seen on Tc-99m DMSA SPECT. Clin Nucl Med, 2003. 28(1): p. 68-9.
Langer, O., et al., In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging, 2005. 32(2): p. 143-50.
Alexander, K., et al., Binding of ciprofloxacin labelled with technetium Tc 99m versus 99mTc-pertechnetate to a live and killed equine isolate of Escherichia coil. Can J Vet Res, 2005. 69(4): p. 272-7.
Palestro, C., et al., Phase II study of 99mTc-ciprofloxacin uptake in patients with high suspicion of osteomyelitis. J NUCL MED MEETING ABSTRACTS, 2006. 47(suppl_1): p. 152P-.
Malamitsi, J., et al., The value of successive Infecton scans in assessing the presence of chronic bone and joint infection and in predicting its evolution after treatment and after a prolonged follow-up. Nucl Med Commun, 2011. 32(11): p. 1060-9.
Bhardwaj, V., et al., Evaluation of adequacy of short-course chemotherapy for extraspinal osteoarticular tuberculosis using 99mTc ciprofloxacin scan. Int Orthop, 2011. 35(12): p. 1869-74.
Mostafa, M., M. Motaleb, and T. Sakr, Labeling of ceftriaxone for infective inflammation imaging using 99m Tc eluted from 99 Mo/99m Tc generator based on zirconium molybdate. Applied Radiation and Isotopes, 2010. 68(10): p. 1959-1963.
Fazli, A., M. Salouti, and M. Mazidi, 99mTc-ceftriaxone, as a targeting radiopharmaceutical for scintigraphic imaging of infectious foci due to Staphylococcus aureus in mouse model. Journal of Radioanalytical and Nuclear Chemistry, 2013. 298(2): p. 1227-1233.
Sohaib, M., Z. Khurshid, and S. Roohi, Labelling of ceftriaxone with 99mTc and its bio-evaluation as an infection imaging agent. Journal of Labelled Compounds and Radiopharmaceuticals, 2014. 57(11): p. 652-657.
Kaul, A., et al., Preliminary evaluation of technetium-99m-labeled ceftriaxone: infection imaging agent for the clinical diagnosis of orthopedic infection. International Journal of Infectious Diseases, 2013. 17(4): p. e263-e270.
van Oosten, M., et al., Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat Commun, 2013. 4: p. 2584.
Auletta, S., et al., Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic review. Clinical and Translational Imaging, 2016. 4(4): p. 229-252.
Rubin, R.H., et al., 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med, 1989. 321(14): p. 935-40.
Panizzi, P., J.R. Stone, and M. Nahrendorf, Endocarditis and molecular imaging. Journal of Nuclear Cardiology, 2014. 21(3): p. 486-495.
Wong, D.W., et al., Imaging endocarditis with Tc-99m-labeled antibody--an experimental study: concise communication. J Nucl Med, 1982. 23(3): p. 229-34.
Pinkston, K.L., et al., Targeting Pili in Enterococcal Pathogenesis. Infection and Immunity, 2014. 82(4): p. 1540-1547.
Rubin, R.H., et al., Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J Nucl Med, 1988. 29(5): p. 651-6.
Wiehr, S., et al., New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection. Oncotarget, 2016. 7(10): p. 10990-11001.
Malpani, B.L., G.V. Kadival, and A.M. Samuel, Radioimmunoscintigraphic approach for the in vivo detection of tuberculomas--a preliminary study in a rabbit model. Int J Rad Appl Instrum B, 1992. 19(1): p. 45-53.
Lee, J.D., et al., Immunoscintigraphy in the detection of tuberculosis with radiolabelled antibody fragment against Mycobacterium bovis bacillus Calmette-Guérin: a preliminary study in a rabbit model. European Journal of Nuclear Medicine and Molecular Imaging, 1992. 19(12): p. 1011-1015.
Oyen, W.J.G., et al., Specific antibody uptake in tuberculosis? European Journal of Nuclear Medicine, 1993. 20(6): p. 568-569.
Leevy, W.M., et al., Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J Am Chem Soc, 2006. 128(51): p. 16476-7.
Leevy, W.M., et al., Noninvasive optical imaging of staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug Chem, 2008. 19(3): p. 686-92.
Liu, X., et al., Radiolabeled Zn-DPA as a potential infection imaging agent. Nucl Med Biol, 2012. 39(5): p. 709-14.
Rice, D.R., et al., Evaluation of [(1)(1)(1)In]-labeled zinc-dipicolylamine tracers for SPECT imaging of bacterial infection. Mol Imaging Biol, 2015. 17(2): p. 204-13.
Rice, D.R., K.J. Clear, and B.D. Smith, Imaging and therapeutic applications of zinc (II)-dipicolylamine molecular probes for anionic biomembranes. Chemical Communications, 2016. 52(57): p. 8787-8801.
Wyffels, L., et al., Synthesis and preliminary evaluation of radiolabeled bis(zinc(II)-dipicolylamine) coordination complexes as cell death imaging agents. Bioorg Med Chem, 2011. 19(11): p. 3425-33.
Wang, H., et al., Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, (18)F labeled bis(zinc(II)-dipicolylamine) complex. Apoptosis, 2013. 18(8): p. 1017-27.
Sun, T., et al., Positron emission tomography imaging of cardiomyocyte apoptosis with a novel molecule probe [18F]FP-DPAZn2. Oncotarget, 2015. 6(31): p. 30579-91.
Kennedy, D.O., B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review. Nutrients, 2016. 8(2): p. 68.
Rusckowski, M., B. Fritz, and D.J. Hnatowich, Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med, 1992. 33(10): p. 1810-5.
Lazzeri, E., et al., Clinical impact of SPECT/CT with In-111 biotin on the management of patients with suspected spine infection. Clin Nucl Med, 2010. 35(1): p. 12-7.
Lazzeri, E., et al., Scintigraphic imaging of vertebral osteomyelitis with 111in-biotin. Spine (Phila Pa 1976), 2008. 33(7): p. E198-204.
Shoup, T.M., et al., Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization. J Nucl Med, 1994. 35(10): p. 1685-90.
Baldoni, D., et al., Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model. Molecular Imaging and Biology, 2015. 17(6): p. 829-837.
Shah, S.Q., M.R. Khan, and S.M. Ali, Radiosynthesis of (99m)Tc(CO)3-Clinafloxacin Dithiocarbamate and Its Biological Evaluation as a Potential Staphylococcus aureus Infection Radiotracer. Nucl Med Mol Imaging, 2011. 45(4): p. 248-54.
Motaleb, M.A., Radiochemical and biological characteristics of 99mTc-difloxacin and 99mTc-pefloxacin for detecting sites of infection. Journal of Labelled Compounds and Radiopharmaceuticals, 2010. 53(3): p. 104-109.
Siaens, R.H., et al., Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin. Journal of Nuclear Medicine, 2004. 45(12): p. 2088-2094.
Shahzad, S., et al., A new method for synthesis of 99m Tc-enorfloxacin: an infection imaging agent. Lat Am J Pharm, 2016. 35: p. 259-264.
Motaleb, M.A., et al., Study on the preparation and biological evaluation of 99mTc–gatifloxacin and 99mTc–cefepime complexes. Journal of Radioanalytical and Nuclear Chemistry, 2011. 289(1): p. 57-65.
Shahzad, S., et al., Synthesis of 99m Tc-gemifloxacin freeze dried kits and their biodistribution in Salmonella typhi, Pseudomonas aeruginosa and Klebsiella pneumoniae. Arabian Journal of Chemistry, 2015.
Shah, S.Q. and M.R. Khan, Radiolabeling of gemifloxacin with technetium-99m and biological evaluation in artificially Streptococcus pneumoniae infected rats. Journal of Radioanalytical and Nuclear Chemistry, 2011. 288(1): p. 307-312.
Shahzad, S., et al., In vivo studies 99m Tc-levofloxacin freeze dried kits in Salmonella typhi, Pseudoman aeruginosa, and Escherichia coli. Lat Am J Pharm, 2015. 34: p. 760-765.
Motaleb, M., Preparation and biodistribution of 99mTc-lomefloxacin and 99mTc-ofloxacin complexes. Journal of Radioanalytical and Nuclear Chemistry, 2007. 272(1): p. 95-99.
Chattopadhyay, S., et al., Synthesis and evaluation of 99m Tc-moxifloxacin, a potential infection specific imaging agent. Applied Radiation and Isotopes, 2010. 68(2): p. 314-316.
Zhang, S., et al., Synthesis and biodistribution of a novel 99mTcN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging. Bioconjugate chemistry, 2011. 22(3): p. 369-375.
Ibrahim, I., M. Motaleb, and K. Attalah, Synthesis and biological distribution of 99mTc–norfloxacin complex, a novel agent for detecting sites of infection. Journal of radioanalytical and nuclear chemistry, 2010. 285(3): p. 431-436.
Sazonova, S.I., et al., Synthesis and experimental study of norfloxacin labeled with technecium-99m as a potential agent for infection imaging. Iranian Journal of Nuclear Medicine, 2015. 23(2): p. 73-81.
Erfani, M., et al., 99mTc-tricabonyl labeling of ofloxacin and its biological evaluation in Staphylococcus aureus as an infection imaging agent. Journal of Labelled Compounds and Radiopharmaceuticals, 2013. 56(12): p. 627-631.
El-Ghany, E., et al., Synthesis of 99mTc-pefloxacin: a new targeting agent for infectious foci. Journal of Radioanalytical and Nuclear Chemistry, 2005. 266(1): p. 131-139.
Motaleb, M. and S. Ayoub, Preparation, quality control, and biodistribution of 99mTc-rufloxacin complex as a model for detecting sites of infection. Radiochemistry, 2013. 55(6): p. 610-614.
Moustapha, M., et al., Synthesis and biological evaluation of technetium-sarafloxacin complex for infection imaging. Journal of Radioanalytical and Nuclear Chemistry, 2016. 307(1): p. 699-705.
Qaiser, S., A. Khan, and M. Khan, Synthesis, biodistribution and evaluation of 99mTc-Sitafloxacin kit: a novel infection imaging agent. Journal of radioanalytical and nuclear chemistry, 2010. 284(1): p. 189-193.
Shah, S.Q., A.U. Khan, and M.R. Khan, Radiosynthesis and biological evaluation of 99mTcN-sitafloxacin dithiocarbamate as a potential radiotracer for Staphylococcus aureus infection. Journal of Radioanalytical and Nuclear Chemistry, 2011. 287(3): p. 827-832.
Motaleb, M., Preparation, quality control and stability of 99mTc-sparafloxacin complex, a novel agent for detecting sites of infection. Journal of Labelled Compounds and Radiopharmaceuticals, 2009. 52(10): p. 415-418.
El-Tawoosy, M., Preparation and biological distribution of 99mTc-cefazolin complex, a novel agent for detecting sites of infection. Journal of Radioanalytical and Nuclear Chemistry, 2013. 298(2): p. 1215-1220.
Motaleb, M., et al., Study on the preparation and biological evaluation of 99mTc–gatifloxacin and 99mTc–cefepime complexes. Journal of Radioanalytical and Nuclear Chemistry, 2011. 289(1): p. 57-65.
Motaleb, M., Preparation of 99mTc-cefoperazone complex, a novel agent for detecting sites of infection. Journal of Radioanalytical and Nuclear Chemistry, 2007. 272(1): p. 167-171.
Mirshojaei, S., et al., Radio labeling, quality control and biodistribution of 99mTc-cefotaxime as an infection imaging agent. Journal of Radioanalytical and Nuclear Chemistry, 2011. 287(1): p. 21-25.
Ilem-Ozdemir, D., et al., Gamma scintigraphy and biodistribution of 99mTc-cefotaxime sodium in preclinical models of bacterial infection and sterile inflammation. Journal of Labelled Compounds and Radiopharmaceuticals, 2016. 59(3): p. 109-116.
Mirshojaei, S., M. Erfani, and M. Shafiei, Evaluation of 99mTc-ceftazidime as bacterial infection imaging agent. Journal of Radioanalytical and Nuclear Chemistry, 2013. 298(1): p. 19-24.
Barreto, V.G., et al., GammagrafÃa con 99mTc-ceftizoxima en ratas normales y en ratas con absceso inducido. Revista Española de Medicina Nuclear, 2005. 24(5): p. 312-318.
Costa, P.H.N., et al., Scintigraphic imaging with technetium-99M-labelled ceftizoxime is a reliable technique for the diagnosis of deep sternal wound infection in rats. Acta Cirurgica Brasileira, 2015. 30(9): p. 632-638.
Teixeira, L.E.M., et al., Efficacy of 99mTc-labeled ceftizoxime in the diagnosis of subclinical infections associated with titanium implants in rats. Surgical infections, 2015. 16(3): p. 352-357.
Chattopadhyay, S., et al., Preparation and evaluation of 99m Tc-cefuroxime, a potential infection specific imaging agent: A reliable thin layer chromatographic system to delineate impurities from the 99m Tc-antibiotic. Applied Radiation and Isotopes, 2012. 70(10): p. 2384-2387.
Yurt Lambrecht, F., et al., Evaluation of 99mTc-Cefuroxime axetil for imaging of inflammation. Journal of Radioanalytical and Nuclear Chemistry, 2008. 277(2): p. 491-494.
Shah, S.Q., A.U. Khan, and M.R. Khan, Radiosynthesis of 99mTc-nitrofurantoin a novel radiotracer for in vivo imaging of Escherichia coli infection. Journal of Radioanalytical and Nuclear Chemistry, 2011. 287(2): p. 417-422.
Shah, S.Q., A.U. Khan, and M.R. Khan, Radiosynthesis and biodistribution of 99m Tc-rifampicin: a novel radiotracer for in-vivo infection imaging. Applied Radiation and Isotopes, 2010. 68(12): p. 2255-2260.
Essouissi, I., et al., Synthesis and evaluation of 99mTc-N-sulfanilamide ferrocene carboxamide as bacterial infections detector. Nuclear Medicine and Biology, 2010. 37(7): p. 821-829.
Tsopelas, C., et al., 99m Tc-Alafosfalin: an antibiotic peptide infection imaging agent. Nuclear medicine and biology, 2003. 30(2): p. 169-175.
Shahzadi, S.K., et al., 99mTc-amoxicillin: A novel radiopharmaceutical for infection imaging. Arabian Journal of Chemistry.
Roohi, S., A. Mushtaq, and S.A. Malik, Synthesis and biodistribution of 99mTc-vancomycin in a model of bacterial infection. Radiochimica Acta, 2005. 93(7): p. 415-418.
Sanad, M., Labeling and biological evaluation of 99mTc-azithromycin for infective inflammation diagnosis. Radiochemistry, 2013. 55(5): p. 539-544.
Borai, E., M. Sanad, and A. Fouzy, Optimized chromatographic separation and biological evaluation of 99m Tc-clarithromycin for infective inflammation diagnosis. Radiochemistry, 2016. 58(1): p. 84-91.
Hina, S., et al., Preparation, biodistribution, and scintigraphic evaluation of 99mTc-clindamycin: an infection imaging agent. Applied biochemistry and biotechnology, 2014. 174(4): p. 1420-1433.
İlem-Özdemir, D., et al., 99mTc-Doxycycline hyclate: a new radiolabeled antibiotic for bacterial infection imaging. Journal of Labelled Compounds and Radiopharmaceuticals, 2014. 57(1): p. 36-41.
Abdel-Ghaney, I. and M. Sanad, Synthesis of 99mTc-erythromycin complex as a model for infection sites imaging. Radiochemistry, 2013. 55(4): p. 418-422.
Roohi, S., et al., Synthesis, quality control and biodistribution of 99mTc-Kanamycin. Journal of radioanalytical and nuclear chemistry, 2006. 267(3): p. 561-566.
Hina, S., et al., Labeling, quality control and biological evaluation of 99m Tc-vibramycin for infection sites imaging. Bulg Chem Comm, 2015. 47: p. 747-754.
Wang, X. and N. Murthy, Bacterial imaging comes of age. Sci Transl Med, 2014. 6(259): p. 259fs43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Ordonez, A.A., Bambarger, L.E., Murthy, N., Wilson, D.M., Jain, S.K. (2017). Bacterial Imaging. In: Jain, S. (eds) Imaging Infections . Springer, Cham. https://doi.org/10.1007/978-3-319-54592-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-54592-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54590-5
Online ISBN: 978-3-319-54592-9
eBook Packages: MedicineMedicine (R0)